Checking your pancreas typically starts with blood tests and may progress to imaging or specialized function tests depending on your symptoms. Because the pancreas sits deep in the abdomen, behind the stomach, it can’t be felt during a routine physical exam. That means doctors rely almost entirely on lab work and imaging to evaluate it. The specific tests you’ll need depend on whether the concern is inflammation, cancer risk, or digestive problems caused by poor enzyme production.
Blood Tests for Pancreatic Problems
The most common first step is a simple blood draw measuring two digestive enzymes: amylase and lipase. Both are produced by the pancreas, and elevated levels signal that something is irritating or damaging the organ. Normal amylase levels for adults fall between 30 and 220 units per liter. When levels rise to more than three times the upper limit of normal, acute pancreatitis becomes the leading concern.
Lipase is generally considered the more reliable of the two markers because it stays elevated longer after a pancreatic episode and is more specific to the pancreas. Your doctor will often order both together. These results can come back within hours, making them useful in emergency settings when someone arrives with sudden, severe upper abdominal pain.
Standard blood work can also reveal clues indirectly. Elevated blood sugar in someone with no prior history of diabetes can sometimes point to pancreatic dysfunction, since the pancreas produces insulin. A sudden, unexplained spike in fasting glucose, particularly in people over 50, is something doctors take seriously as a potential early signal of pancreatic disease.
Imaging Tests That Visualize the Pancreas
CT Scan
A contrast-enhanced CT scan is the most widely used first-line imaging tool for the pancreas. It’s fast, widely available, and good at detecting inflammation, fluid collections, and masses. For suspected acute pancreatitis or a visible tumor, CT is typically the starting point. Its main limitation is that it’s less precise at characterizing smaller or cystic lesions, so further imaging is often needed if something ambiguous shows up.
MRI and MRCP
MRI provides superior soft-tissue contrast compared to CT, making it better for evaluating cysts, duct abnormalities, and subtle changes in pancreatic tissue. A specialized version called MRCP (magnetic resonance cholangiopancreatography) creates detailed images of the pancreatic and bile ducts without requiring any invasive procedure. MRI has a sensitivity of 100% for distinguishing cystic from solid lesions and an overall accuracy between 90% and 98% for characterizing pancreatic cysts. It’s also effective at detecting internal structures like internal walls within cysts (94.4% sensitivity) and dilated ducts (up to 92.9% sensitivity). Because it’s noninvasive and highly informative, MRI is often the preferred test when doctors need to plan treatment.
Endoscopic Ultrasound (EUS)
Endoscopic ultrasound involves passing a thin, flexible scope through the mouth and into the small intestine, positioning an ultrasound probe just millimeters from the pancreas. This proximity gives it extremely high resolution for visualizing small lesions. Its biggest advantage over MRI is that a tissue sample can be taken during the same procedure, combining imaging and biopsy in one step. Overall accuracy for distinguishing cystic from solid lesions is about 88%, slightly lower than MRI, but the ability to collect cells for analysis makes it invaluable when a diagnosis needs to be confirmed.
How Preparation Differs by Test
For an abdominal ultrasound, you’ll need to fast for eight hours beforehand, though water and medications are fine. This keeps the bowel clear of gas and food that could obscure the view. CT scans with contrast also require fasting, typically for four to six hours, and you may need to drink an oral contrast solution before the scan. MRI requires similar fasting but takes longer to perform, usually 30 to 45 minutes in the machine compared to a few minutes for CT. Endoscopic ultrasound requires sedation, so you’ll need someone to drive you home and should expect to fast overnight.
Testing How Well Your Pancreas Works
Sometimes the question isn’t whether the pancreas looks abnormal on a scan but whether it’s producing enough digestive enzymes. This is where function tests come in.
The simplest is a stool elastase test. Elastase is a digestive enzyme the pancreas makes, and it passes through the gut largely intact. You provide a stool sample, and the lab measures how much elastase is present. Low levels indicate exocrine pancreatic insufficiency (EPI), meaning the pancreas isn’t releasing enough enzymes to properly digest food. This test is better at catching severe insufficiency than mild cases, and a normal result doesn’t completely rule out EPI. Symptoms that prompt this test include persistent diarrhea, oily or foul-smelling stools, unexplained weight loss, and bloating after meals.
A more involved option is the secretin stimulation test. A thin tube is passed through the nose into the small intestine, and then you receive an injection of secretin, a hormone that normally triggers the pancreas to release digestive fluid rich in bicarbonate. Over roughly two hours, the fluid is collected and analyzed. If the pancreas responds with normal bicarbonate output, it’s functioning well. Low output confirms the pancreas is underperforming. This test is highly accurate but time-consuming, so it’s reserved for cases where simpler tests haven’t given a clear answer.
Pancreatic Biopsy
When imaging reveals a suspicious mass or cyst, a biopsy is often the next step. The most common method is EUS-guided fine needle aspiration, where a thin needle is passed through the endoscope and into the pancreatic lesion to collect cells. For small pancreatic tumors (10 mm or less), the procedure has a technical success rate of about 81%, with sensitivity of 82% and overall accuracy of 91% for detecting pancreatic cancer. When the needle biopsy comes back negative but suspicion remains high, doctors can sometimes collect pancreatic juice for additional analysis, which correctly identifies cancer in about 74% of those initially missed cases.
Genetic Testing for Hereditary Risk
Some people inherit gene mutations that significantly raise their risk of pancreatitis and pancreatic cancer. The best-known is a mutation in the PRSS1 gene, which causes hereditary pancreatitis and carries an elevated lifetime risk of pancreatic cancer. Other relevant genes include SPINK1, CFTR (the gene linked to cystic fibrosis), CTRC, CPA1, CASR, and CLDN2. Genetic testing panels now screen for all of these simultaneously.
If you have two or more close relatives who’ve had pancreatic cancer, or if you’ve experienced unexplained recurrent pancreatitis starting at a young age, genetic testing can clarify whether you carry one of these mutations. A positive result changes how aggressively and how early monitoring begins.
Screening for People at High Risk
For the general population, there’s no routine pancreatic cancer screening test. But for people with a strong family history or known genetic mutations, expert guidelines recommend annual surveillance. A National Cancer Institute study followed roughly 1,700 high-risk individuals who underwent yearly imaging with MRI and/or endoscopic ultrasound. The goal is to catch pancreatic changes at an early, treatable stage rather than after symptoms appear, since pancreatic cancer is notoriously silent until it’s advanced.
If you fall into a high-risk category, screening typically starts between ages 40 and 50, or 10 years before the youngest case in your family, whichever comes first. The screening itself alternates between MRI and endoscopic ultrasound on an annual basis, with more frequent imaging if anything concerning is found.
Why a Physical Exam Has Limits
The pancreas is about six inches long and sits deep in the upper abdomen, tucked behind the stomach and in front of the spine. A doctor can’t feel it through the abdominal wall during a standard exam. Physical signs of pancreatic trouble only show up in severe cases. Cullen’s sign, a bruise-like discoloration around the belly button, and Grey Turner’s sign, similar discoloration along the flanks, are associated with severe acute pancreatitis and internal bleeding. These are late, serious findings rather than early warning signs. For meaningful evaluation of the pancreas, lab work and imaging are essential.